"Baroreflex" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.
| Descriptor ID |
D017704
|
| MeSH Number(s) |
G09.330.380.057 G11.561.731.063
|
| Concept/Terms |
Baroreflex- Baroreflex
- Baroreceptor Reflexes
- Reflexes, Baroreceptor
- Baroreflexes
- Baroreceptor Reflex
- Reflex, Baroreceptor
|
Below are MeSH descriptors whose meaning is more general than "Baroreflex".
Below are MeSH descriptors whose meaning is more specific than "Baroreflex".
This graph shows the total number of publications written about "Baroreflex" by people in this website by year, and whether "Baroreflex" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 3 | 0 | 3 |
| 2018 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Baroreflex" by people in Profiles.
-
Baroreflex activation therapy with the Barostim? device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. Eur J Heart Fail. 2022 09; 24(9):1665-1673.
-
Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart?Failure. JACC Heart Fail. 2021 06; 9(6):430-438.
-
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States. BMC Cardiovasc Disord. 2021 03 26; 21(1):155.
-
Baroreflex Activation Therapy in Patients With Heart?Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2020 07 07; 76(1):1-13.
-
Both CRF1 and CRF2 receptors in the bed nucleus of stria terminalis are involved in baroreflex impairment evoked by chronic stress in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2021 03 08; 105:110009.
-
First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF. Am Heart J. 2018 10; 204:139-150.
-
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. Int J Cardiol. 2018 Sep 01; 266:187-192.
-
Carotid baroreceptor stimulation blood pressure response mapped in patients undergoing carotid endarterectomy (C-Map study). Auton Neurosci. 2016 12; 201:60-67.
-
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction. Semin Thorac Cardiovasc Surg. 2016 Summer; 28(2):320-328.
-
Restoring Sinus Rhythm Improves Baroreflex Function in Patients With Persistent Atrial Fibrillation. J Am Heart Assoc. 2016 Feb 23; 5(2).